Paper5623969
Soluble antigens of vaccinia-infected mammalian cells. II. Time course of synthesis of soluble antigens and virus structural proteins.
Wilcox WC and 1 other. J Virol, 1967. Cited by 17 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Soluble antigens of vaccinia-infected mammalian cells. II. Time course of synthesis of soluble antigens and virus structural proteins. Papers, record 5623969. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5623969
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Soluble antigens of vaccinia-infected mammalian cells. II. Time course of synthesis of soluble antigens and virus structural proteins.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens | Major topic |
| Cytopathogenic Effect, Viral | Major topic |
| Molecular Weight | Major topic |
| Vaccinia virus | Major topic |
| Viral Proteins | Major topic |
| Carcinoma | |
| Cell Line | |
| Complement Fixation Tests | |
| Humans | |
| Immune Sera | |
| Mouth Neoplasms | |
| Neutralization Tests | |
| Solubility | |
| Thymidine Kinase |
Source PubMed
References12
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4,157,610 | Studies on "early" enzymes in HeLa cells infected with vaccinia virus. | Virology | 1965 | https://conductscience.org/library/papers/4157610 | PubMed |
| 2 | 5,922,541 | Soluble antigens of vaccinia-infected mammalian cells. I. Separation of virus-induced soluble antigens into two classes on the basis of physical characteristics. | J Bacteriol | 1966 | https://conductscience.org/library/papers/5922541 | PubMed |
| 3 | 4,289,825 | Localization of avian tumor virus group-specific antigen in cell and virus. | Virology | 1966 | https://conductscience.org/library/papers/4289825 | PubMed |
| 4 | 13,763,191 | Demonstration of the sequential development of vaccinial antigens and virus in infected cells: observations with cytochemical and differential fluorescent procedures. | J Exp Med | 1961 | https://conductscience.org/library/papers/13763191 | PubMed |
| 5 | 14,452,174 | The preparation and characteristics of highly purified radioactively labelled poxvirus. | Biochim Biophys Acta | 1962 | https://conductscience.org/library/papers/14452174 | PubMed |
| 6 | 13,910,995 | Application of a microtechnique to viral serological investigations. | J Immunol | 1962 | https://conductscience.org/library/papers/13910995 | PubMed |
| 7 | 13,950,095 | Studies on the biosynthesis of viral DNA. | Cold Spring Harb Symp Quant Biol | 1962 | https://conductscience.org/library/papers/13950095 | PubMed |
| 8 | 13,976,928 | The formation of vaccinia virus protein in the presence of 5-fluorodeoxyuridine. | Virology | 1963 | https://conductscience.org/library/papers/13976928 | PubMed |
| 9 | 13,991,265 | Viral protein and DNA synthesis in vaccinia virus-infected HeLacell cultures. | Virology | 1963 | https://conductscience.org/library/papers/13991265 | PubMed |
| 10 | 14,140,751 | A PROTECTIVE ANTIGEN FROM THE POX-VIRUSES. I. REACTION WITH NEUTRALIZING ANTIBODY. | Br J Exp Pathol | 1964 | https://conductscience.org/library/papers/14140751 | PubMed |
| 11 | 14,255,112 | THE REPLICATION AND COATING OF VACCINIA DNA. | J Mol Biol | 1964 | https://conductscience.org/library/papers/14255112 | PubMed |
| 12 | 14,293,309 | PROPERTIES OF DEOXYTHYMIDINE KINASE PARTIALLY PURIFIED FROM NONINFECTED MOUSE FIBROBLAST CELLS. | Virology | 1965 | https://conductscience.org/library/papers/14293309 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 5,822,902 | Rifampicin and poxvirus replication. | Nature | 1969 | https://conductscience.org/library/papers/5822902 | PubMed |
| 5,688,397 | Soluble antigens of vaccinia-infected mammalian cells. 3. Relation of "early" and "late" proteins to virus structure. | J Virol | 1968 | https://conductscience.org/library/papers/5688397 | PubMed |
| 4,873,813 | Recent progress in poxvirus research. | Bacteriol Rev | 1968 | https://conductscience.org/library/papers/4873813 | PubMed |
| 4,624,399 | A comparison of the antigens present on the surface of virus released artificially from chick cells infected with vaccinia virus, and cowpox virus and its white pock mutant. | J Hyg (Lond) | 1972 | https://conductscience.org/library/papers/4624399 | PubMed |
| 4,317,348 | Immunodiffusion analysis of Yaba poxvirus structural and associated antigens. | J Virol | 1970 | https://conductscience.org/library/papers/4317348 | PubMed |
| 4,317,347 | Growth kinetics of Yaba tumor poxvirus after in vitro adaptation to cercopithecus kidney cells. | J Virol | 1970 | https://conductscience.org/library/papers/4317347 | PubMed |
| 4,250,367 | Vaccinia virus structural polypeptide derived from a high-molecular-weight precursor: formation and integration into virus particles. | J Virol | 1970 | https://conductscience.org/library/papers/4250367 | PubMed |
| 4,235,537 | Sequential protein synthesis following vaccinia virus infection. | J Virol | 1968 | https://conductscience.org/library/papers/4235537 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/5623969
GET https://conductscience.org/api/papers/v1/5623969/authors